Summit Therapeutics
SMMT
#2184
Rank
S$10.80 B
Marketcap
S$13.51
Share price
-0.85%
Change (1 day)
-37.53%
Change (1 year)

EPS for Summit Therapeutics (SMMT)

EPS in 2026 (TTM): S-$1.38

According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$1.38. In 2025 the company made an earnings per share (EPS) of S-$1.87.

EPS history for Summit Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$1.38-26.43%
2025S-$1.87
2021S-$1.2426.32%
2020S-$0.98
2018S-$0.05595-84.63%
2017S-$0.36-40.59%
2016S-$0.616.54%
2015S-$0.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
S-$3.39 145.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
S$17.87-1,395.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
S-$1.33-3.74%๐Ÿ‡บ๐Ÿ‡ธ USA